Blood-pressure lowering effects of zilebesiran found in hypertensive patients at high cardiovascular risk
Among individuals with cardiovascular disease or high cardiovascular risk and uncontrolled hypertension on multiple anti-hypertensive agents, a single subcutaneous dose of zilebesiran 300 mg led to a 5-mmHg reduction in systolic ...
Sep 1, 2025
0
0